Prospective Evaluation of Facial Cosmetic Procedures

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

February 28, 2024

Study Completion Date

May 29, 2024

Conditions
Cosmetic Techniques
Interventions
DRUG

Restylane-L®

Restylane-L® for the indication for mid-to-deep dermal implantation for moderate to severe facial wrinkles and folds, such as nasolabial folds.

DRUG

Restylane-L® Lyft

Restylane-L® Lyft is for the indication of implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds and malars (cheek/cheek bone area).

DRUG

Restylane Silk®

Restylane Silk® is for the indication for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids in patients over the age of 21.

Trial Locations (1)

19104

University of Pennsylvania Health System, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Galderma R&D

INDUSTRY

lead

University of Pennsylvania

OTHER